港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

高瓴概念

536.305

-8.338-1.53%

涨家数：9

跌家数：41

平家数：5

市盈率：- -

高：548.851

开：544.657

低：534.195

收：544.643

数据加载中...

3 款创新药在中国获批，来自强生、阿斯利康、李氏大药厂

Insight数据库

泰格医药遭易方达基金减持27.31万股

药明康德(02359.HK)拟折让约6.90%配售7380万股新H股净筹约76.5亿港元

药明康德(02359.HK)拟配售7380万股H股总筹77亿港元加速全球布局

药明康德：拟折价6.9%配售7380万股H股筹资77亿港元

京东健康与翰森制药深化合作，打造药品全链路数字化通路

浙商重点推荐||爱康医疗·王班/司清蕊

浙商证券研究所

锚定精致餐饮海底捞全场景布局再进阶

Prosus启动减持美团股份规模达40亿美元

兆科眼科-B(06622)：用于治疗儿童视网膜母细胞瘤的美法仑取得美国FDA孤儿药资格认证

Morgan Stanley增持药明康德(02359)约192.96万股每股作价约95.86港元

中信证券-开元单一资产管理计划增持中广核电力1787.2万股每股作价约2.98港元

智通财经网

中信证券-开元单一资产管理计划增持中广核电力(01816.HK)1787.2万股每股作价约2.98港元

开出客单价700元的甄选店，能否缓解海底捞的焦虑？

为什么要冲器械龙头

北海茶客投研笔记

人民荟客厅｜冯全服：企业创新转型的“三个关键词”

15亿！广药大动作

信义能源(03868)7月30日发行7658.2万股代息股份

药明康德：2Q25业绩显著超预期，上调全年指引

浦银国际研究

汇宇制药(688553.SH)：注射用HY0001a I期临床试验首例受试者给药

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1583/news?page=11"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":536.3049,"timestamp":1754035689688,"preClose":544.6429,"halted":0,"volume":1273915179,"delay":0,"changeRate":-0.015309,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-8.338013,"latestTime":"08-01 16:00:00","open":544.6572,"high":548.851,"low":534.19507,"amount":21412358748.8,"amplitude":0.026909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754271000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1754011800000,1754020800000],[1754024400000,1754035200000]],"pbRate":2.560761,"peRate":23.337834,"turnoverRate":0.009141,"increases":6,"decrements":43,"flats":4,"marketCap":3097820304512,"floatMarketCap":2380639946624},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":548.851,"amplitude":0.026909,"preClose":544.6429,"low":534.19507,"pbRate":"2.560761","latestPrice":536.3049,"volume":1273915179,"delay":0,"open":544.6572,"prevYearClose":446.93042,"prevWeekClose":548.862,"prevMonthClose":544.643,"prevQuarterClose":500.645,"fiveDayClose":548.862,"twentyDayClose":502.828,"sixtyDayClose":482.232,"secType":"PLATE","market":"HK","turnoverRate":0.009141,"peRate":23.337834,"marketCap":3097820304512,"floatMarketCap":2380639946624,"timestamp":1754035689688,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":9,"down":41,"flat":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555680075","title":"3 款创新药在中国获批，来自强生、阿斯利康、李氏大药厂","url":"https://stock-news.laohu8.com/highlight/detail?id=2555680075","media":"Insight数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555680075?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 08:09","pubTimestamp":1753920565,"startTime":"0","endTime":"0","summary":"2025 年 4 月 15 日，该药在中国首次获批上市，与常规治疗药物联合用于治疗抗乙酰胆碱受体抗体阳性的成人全身型重症肌无力患者。本次获批的是瑞利珠单抗在华申报的第二项适应症。2022 年 10 月，阿斯利康公布该试验的阳性结果。Insight 数据库显示，此前国内仅有 3 款新药获批用于 NMOSD，除阿斯利康的依库珠单抗之外，还有翰森制药引进的的 CD19 单抗“伊奈利珠单抗”和罗氏制药的 IL6R 单抗“萨特利珠单抗”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731082915a46c52b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731082915a46c52b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1191","BK1587","AZN","BK1574","06978","BK1583","BK1161","JNJ","00950"],"gpt_icon":0},{"id":"2555075659","title":"泰格医药遭易方达基金减持27.31万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2555075659","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555075659?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 07:53","pubTimestamp":1753919580,"startTime":"0","endTime":"0","summary":"格隆汇7月31日丨根据联交所最新权益披露资料显示，2025年7月24日，泰格医药(03347.HK)遭易方达基金管理有限公司在场内以每股均价50.0506港元减持27.31万股，涉资约1366.88万港元。减持后，易方达基金管理有限公司最新持股数目为1351.47万股，持股比例由11.20%下降至10.98%。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731075455a6ca6065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731075455a6ca6065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","BK1583","03347"],"gpt_icon":0},{"id":"2555073831","title":"药明康德(02359.HK)拟折让约6.90%配售7380万股新H股 净筹约76.5亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555073831","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555073831?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 07:51","pubTimestamp":1753919500,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1969619763.USD","LU1997245094.SGD","LU2328871848.SGD","603259","LU0320764599.SGD","LU0708995583.HKD","LU2045819591.USD","LU2242644610.SGD","LU1934453819.USD","LU1046422090.SGD","LU2125910500.SGD","BK0216","LU1979443071.USD","LU2488822045.USD","BK1141","BK1576","LU1997244956.HKD","LU1997245177.USD","02359","BK1583","LU2495084118.USD","LU0052750758.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2555056078","title":"药明康德(02359.HK)拟配售7380万股H股 总筹77亿港元加速全球布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2555056078","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555056078?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 07:38","pubTimestamp":1753918708,"startTime":"0","endTime":"0","summary":"配售股份数目分别占：截至本公告日期现有已发行H股总数及现有已发行股份总数约19.07%及2.57%；及紧随完成后经发行配售股份扩大后的已发行H股总数及已发行股份总数约16.01%及2.51%。配售股份将根据一般授权予以发行。公司将向香港联交所上市委员会申请批准配售股份上市及买卖。假设所有配售股份获悉数认购，配售的募集资金总额预计将约为77.0亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/31073852100747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1997245094.SGD","LU2495084118.USD","LU1997245177.USD","LU1979443071.USD","LU1969619763.USD","BK0216","BK1576","LU2045819591.USD","LU0456842615.SGD","LU0708995583.HKD","LU0320764599.SGD","LU2125910500.SGD","LU2328871848.SGD","LU0052750758.USD","LU1046422090.SGD","BK1141","BK1583","LU2242644610.SGD","LU1934453819.USD","LU2488822045.USD","603259","LU1997244956.HKD","02359"],"gpt_icon":1},{"id":"2555078710","title":"药明康德：拟折价6.9%配售7380万股H股 筹资77亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555078710","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555078710?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 07:38","pubTimestamp":1753918705,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1583","LU1969619763.USD","BK0216","LU2328871848.SGD","LU1997245094.SGD","LU1046422090.SGD","BK1141","HEXmain","LU2242644610.SGD","LU2045819591.USD","LU0052750758.USD","LU2488822045.USD","LU1934453819.USD","LU1997244956.HKD","LU2495084118.USD","LU1979443071.USD","02359","LU0320764599.SGD","LU2125910500.SGD","LU1997245177.USD","603259","LU0708995583.HKD","BK1576","LU0456842615.SGD"],"gpt_icon":0},{"id":"2555072803","title":"京东健康与翰森制药深化合作，打造药品全链路数字化通路","url":"https://stock-news.laohu8.com/highlight/detail?id=2555072803","media":"砍柴网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555072803?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 00:00","pubTimestamp":1753891200,"startTime":"0","endTime":"0","summary":"2025年7月29日，京东健康宣布与翰森制药深化合作，双方将共同迈入更深的协同合作阶段。2025年上半年，京东健康与翰森制药在多个领域的合作均取得显著成效。针对抗感染领域，京东健康依托药师等角色的专业服务能力，有效提升患者用药依从性；针对呼吸领域，京东健康则通过构建整体健康解决方案，有效加强患者认知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507311100439729159e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507311100439729159e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06618","LU0051755006.USD","86618","BK1583","BK1247","BK1571","03692","BK1591","BK1142","LU0456827905.SGD","BK1191","BK1589","BK1615","BK1515"],"gpt_icon":0},{"id":"2555602565","title":"浙商重点推荐||爱康医疗·王班/司清蕊","url":"https://stock-news.laohu8.com/highlight/detail?id=2555602565","media":"浙商证券研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555602565?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 23:30","pubTimestamp":1753889435,"startTime":"0","endTime":"0","summary":"重点覆盖医疗器械、连锁药店领域。“重点推荐”①逻辑特别清晰；②上涨趋势明朗，一般右侧推荐。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731000945a46be592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731000945a46be592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","01789","BK1583","BK1617","BK1585"],"gpt_icon":0},{"id":"2555042039","title":"锚定精致餐饮 海底捞全场景布局再进阶","url":"https://stock-news.laohu8.com/highlight/detail?id=2555042039","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555042039?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 21:24","pubTimestamp":1753881840,"startTime":"0","endTime":"0","summary":"业内人士指出，臻选店的亮相是海底捞抢占精致餐饮新蓝海的前瞻性布局，不仅丰富了其品牌矩阵，也提升了高端形象，高端火锅赛道竞争格局或将改写。海底捞臻选店负责人表示。今年3月，海底捞公布2024年年度业绩报告的同时，还透露了“红石榴计划”的进度。由此可见，不仅是传统餐厅，精致餐饮的需求变迁正重塑火锅市场格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730212653a46bb29c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730212653a46bb29c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1233","BK1604","BK1589","08496","06862","BK1583","BK1132","LU2488822045.USD","BK1591"],"gpt_icon":0},{"id":"2555049591","title":"Prosus启动减持美团股份 规模达40亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555049591","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555049591?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 19:54","pubTimestamp":1753876443,"startTime":"0","endTime":"0","summary":"7月30日，投资集团Prosus宣布启动减持美团股份计划，规模达40亿美元。此次减持通过市场交易进行，旨在优化资产配置。Prosus为腾讯控股的主要股东，此前已多次减持中国互联网企业股份。市场分析认为，此举反映其进一步调整投资策略。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507301958249727b601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507301958249727b601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0048580855.USD","LU2226246903.HKD","LU1188198961.HKD","LU1282648689.USD","LU0455707207.USD","LU0499858438.USD","LU1961090484.USD","BK1604","LU0979878070.USD","LU1242518857.USD","LU2097828557.USD","LU0326950275.SGD","BK1610","LU0593848301.USD","LU1048596156.SGD","LU0049853897.USD","LU0307460666.USD","LU0051755006.USD","HMTD.SI","BK1583","LU0348814723.USD","LU0541501648.USD","IE0034224299.USD","LU0269904917.USD","LU0509642566.USD","METmain","LU1880383440.USD","LU0823039010.USD","MPNGY","LU1720050803.USD","LU0348805143.USD","LU1868838027.USD","LU0588545490.SGD","IE00B3M56506.USD","03690","LU1102505762.USD","LU1102505929.USD","LU0828237940.HKD","LU0251144936.SGD","LU0149721374.USD","LU0315178854.USD","LU1328277881.USD","LU0231483743.USD","LU1226287529.USD","LU0326948709.USD","LU0173614495.USD","LU0572944931.SGD","BK1233","LU0588546209.SGD","83690","LU0672654166.SGD"],"gpt_icon":0},{"id":"2555430360","title":"兆科眼科-B(06622)：用于治疗儿童视网膜母细胞瘤的美法仑取得美国FDA孤儿药资格认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2555430360","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555430360?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 19:10","pubTimestamp":1753873815,"startTime":"0","endTime":"0","summary":"智通财经APP讯，兆科眼科-B 发布公告，美国食品药品监督管理局已向公司拥有专利配方、用于治疗儿童视网膜母细胞瘤的美法仑授出孤儿药资格认证。再者，如果美法仑获成功研发并获批准，公司将在新药上市申请批准后享有七年美国市场独家权利。此项完善保护涵盖上市许可持有人地位及数据独家权利，尤其重要的是，即使配方有所创新，FDA亦不得批准任何其他以美法仑为基础的RB适应症产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"兆科眼科-B(06622)：用于治疗儿童视网膜母细胞瘤的美法仑取得美国FDA孤儿药资格认证","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06622","BK1574","BK1583","BK1587"],"gpt_icon":0},{"id":"2555045529","title":"Morgan Stanley增持药明康德(02359)约192.96万股 每股作价约95.86港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555045529","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555045529?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 18:57","pubTimestamp":1753873066,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月24日，Morgan Stanley增持药明康德(02359)192.9554万股，每股作价95.8573港元，总金额约为1.85亿港元。增持后最新持股数目约为2058.81万股，持股比例为5.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0795875169.SGD","LU2045819591.USD","LU0795875086.SGD","BK4504","MSPQV","LU1548497426.USD","LU2111349929.HKD","LU0267386448.USD","LU1989772840.SGD","LU2133065610.SGD","LU0912757837.SGD","LU1934453819.USD","LU2028103732.USD","LU1363072403.SGD","LU1997244956.HKD","LU1668664300.SGD","BK1583","BK4588","MSPQL","LU1997245094.SGD","LU1997245177.USD","LU1732799900.SGD","LU0234570918.USD","LU2271345857.HKD","LU1989772923.USD","LU0158827781.USD","LU2089283258.USD","BK1141","BK4534","LU0708995583.HKD","IE00BKVL7J92.USD","LU0106831901.USD","BK4127","LU2347655156.SGD","LU0006306889.USD","LU1046422090.SGD","LU1074936037.SGD","IE00BZ1G4Q59.USD","02359","BK1576","LU1720051108.HKD","LU0320764599.SGD","LU2357305700.SGD","LU2023251221.USD","LU0098860793.USD","LU0106261372.USD","603259","LU0971096721.USD","LU1969619763.USD","LU1979443071.USD"],"gpt_icon":0},{"id":"2555122046","title":"中信证券-开元单一资产管理计划增持中广核电力1787.2万股 每股作价约2.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555122046","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555122046?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 18:47","pubTimestamp":1753872464,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，7月29日，中信证券-开元单一资产管理计划增持中广核电力(01816)1787.2万股，每股作价2.9774港元，总金额约为5321.21万港元。增持后最新持股数目约为10.06亿股，持股比例为9.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073019110894c3b81c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073019110894c3b81c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1524","BK1583","BK1505","01816","LU1794554557.SGD","BK1594","BK1542","BK1258","06030","BK1516","09983","LU1720050803.USD","BK1125","BK1564","BK1229","BK1147","BK1521"],"gpt_icon":0},{"id":"2555043039","title":"中信证券-开元单一资产管理计划增持中广核电力(01816.HK)1787.2万股 每股作价约2.98港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555043039","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555043039?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 18:47","pubTimestamp":1753872464,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1594","LU1997244956.HKD","LU1064130708.USD","BK1125","BK0188","BK1542","LU1328615791.USD","BK1524","06030","BK0276","LU1997245094.SGD","BK1258","BK1229","LU1064131003.USD","BK1564","LU1655091616.SGD","09983","BK1147","BK1505","BK1516","BK1583","BK0012","LU1720050803.USD","LU2289578879.USD","BK0183","BK1521","01816","LU2495084118.USD","LU1794554557.SGD","LU1997245177.USD","BK0196","LU0405327494.USD","LU2148510915.USD","600030","BK0028","LU0405327148.USD"],"gpt_icon":0},{"id":"2555304510","title":"开出客单价700元的甄选店，能否缓解海底捞的焦虑？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555304510","media":"观网财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555304510?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 17:55","pubTimestamp":1753869306,"startTime":"0","endTime":"0","summary":"相较于常规的海底捞门店，甄选店从环境、产品到服务都更为精致，兼具着日常用餐和商务宴请的功能，目前，门店的晚市几乎是满座的状态。截至目前，海底捞已经推出了涵盖烘焙、烤鱼、烧烤、小火锅、麻辣烫、炸鸡等多个品类的副牌，客单价从近百元到低于50元不等，但主要侧重于中低端市场。在不断推出各种副牌的同时，海底捞也陆续推出了包间店、亲子主题店、夜宵主题店以及与大型企业合作的企业店等不同形式的特色场景店。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730184249a6c99345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730184249a6c99345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06862","BK1604","BK1591","BK1589","LU2488822045.USD","BK1583","BK1233"],"gpt_icon":0},{"id":"2555045237","title":"为什么要冲器械龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2555045237","media":"北海茶客投研笔记","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555045237?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 17:48","pubTimestamp":1753868934,"startTime":"0","endTime":"0","summary":"这种畸形的股权结构使得微创的单项业务每一个都很有竞争力，但整体就是不赚钱。我想没有多少人能想到，微创医疗在熊市中居然可以跌95%：但是最近这个股权结构的调整，从逻辑上是确实可以改善这个公司的利益格局的：一方面，老板的股权比例大概率会上升为第一大，跟小股东的利益便更加一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730185128a46b75db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730185128a46b75db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","00853","BK1100","BK1585","BK1589"],"gpt_icon":1},{"id":"2555704992","title":"人民荟客厅｜冯全服：企业创新转型的“三个关键词”","url":"https://stock-news.laohu8.com/highlight/detail?id=2555704992","media":"金台资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555704992?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 17:40","pubTimestamp":1753868417,"startTime":"0","endTime":"0","summary":"“创新对生物医药企业而言可谓命脉所在，我们在创新转型中总结出三个关键词：人才升级、开放合作、持续投入。”先声药业有限公司副总裁冯全服在交流发言中分享了企业在科技创新与产业创新融合发展的实践。据了解，今年3月，先声药业神经与肿瘤药物研发全国重点实验室发布“求索计划”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730174236a46b59cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730174236a46b59cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1191","BK1583","BK1161","02096","BK1574"],"gpt_icon":0},{"id":"2555961049","title":"15亿！广药大动作","url":"https://stock-news.laohu8.com/highlight/detail?id=2555961049","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555961049?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 17:33","pubTimestamp":1753867988,"startTime":"0","endTime":"0","summary":"继“华润系”参投基金押注生物药后，广州白云山拟出资14.985亿元入局。01广州白云山布局生物医药近日，广药旗下上市公司广州白云山医药集团股份有限公司发布公告称，拟作为有限合伙人以自有资金出资14.985亿元参与设立广州广药基金二期股权投资合伙企业。本次白云山拟出资金额占广药基金二期认缴出资总额99.90%，剩余0.015亿元由广州广药资本私募基金管理有限公司认缴，占比0.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730191639a46b8048&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730191639a46b8048&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","01952","09939","BK1161","BK1515","06978"],"gpt_icon":0},{"id":"2555658014","title":"信义能源(03868)7月30日发行7658.2万股代息股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2555658014","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555658014?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 17:23","pubTimestamp":1753867401,"startTime":"0","endTime":"0","summary":"智通财经APP讯，信义能源(03868)发布公告，于2025年7月30日，根据截至2024年12月31日止年度的末期股息的以股代息计划发行7658.2万股代息股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1594","BK1554","03868","BK1154"],"gpt_icon":0},{"id":"2555041015","title":"药明康德：2Q25业绩显著超预期，上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2555041015","media":"浦银国际研究","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555041015?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 17:17","pubTimestamp":1753867070,"startTime":"0","endTime":"0","summary":"浦银国际研究●2Q25持续经营收入+25% YoY,经调整Non-IFRS归母净利润+47.9% YoY，显著超市场预期：公司1H25实现收入人民币207.99亿元，其中持续经营业务收入为204.1亿元，经调整Non-IFRS归母净利润63.15亿元，均与此前正面盈利预告一致，显著超出盈利预告前的市场预期。截至6月底，TIDES在手订单同比增长48.8% YoY。图表以上内容节选自浦银国际证券于2025年7月30日发布的研究报告《药明康德：2Q25业绩显著超预期，上调全年指引》，欲览报告详情，请点击下方阅读原文。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730195016a6c9ad8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730195016a6c9ad8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU2125910500.SGD","02359","BK1576","LU0052750758.USD","LU0708995583.HKD","LU2242644610.SGD","LU0320764599.SGD","LU1046422090.SGD","BK1141","LU2045819591.USD"],"gpt_icon":1},{"id":"2555301969","title":"汇宇制药(688553.SH)：注射用HY0001a I期临床试验首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2555301969","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555301969?lang=zh_cn&edition=fundamental","pubTime":"2025-07-30 16:42","pubTimestamp":1753864964,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汇宇制药 发布公告，公司全资子公司四川汇宇海玥医药科技有限公司自主研发的1类生物创新药注射用HY0001a正在开展用于治疗晚期实体瘤的I期临床试验，于近日成功完成首例受试者给药。截至本公告披露日，国内外尚无同靶点产品获批上市。临床前研究表明，HY0001a在多种实体瘤模型中表现出优秀的抗肿瘤效果且安全性良好，具有巨大的临床开发价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1323622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","BK1583","BK0239","688553","03347"],"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":11,"totalSize":1075,"code":"91000000","status":"200"}]}}